John Cahill, MD, PhD
Associate Professor of PsychiatryDownloadHi-Res Photo
Cards
Appointments
Psychiatry
Primary
Additional Titles
Residency Program Director, Psychiatry
Deputy Medical Director, Connecticut Mental Health Center
Chief of Behavioral Health, Continuum of Care Inc., --
Contact Info
Appointments
Psychiatry
Primary
Additional Titles
Residency Program Director, Psychiatry
Deputy Medical Director, Connecticut Mental Health Center
Chief of Behavioral Health, Continuum of Care Inc., --
Contact Info
Appointments
Psychiatry
Primary
Additional Titles
Residency Program Director, Psychiatry
Deputy Medical Director, Connecticut Mental Health Center
Chief of Behavioral Health, Continuum of Care Inc., --
Contact Info
About
Titles
Associate Professor of Psychiatry
Residency Program Director, Psychiatry; Deputy Medical Director, Connecticut Mental Health Center
Positions outside Yale
Chief of Behavioral Health, Continuum of Care Inc., --
Biography
Dr. Cahill is interested in building academic Learning Healthcare Systems founded on multi-stakeholder engagement. His background spans EEG biomarker development; clinical trials; DevOps of clinical informatics systems; the care of severe mental illness and transformative leadership. He has 20 years of experience in community psychiatry across both the US and UK. He and co-authors introduced 'deprescribing' to the the field of psychiatry as a means to promote minimum-effective dosing of medications; and to integrate psychodynamic and social justice perspectives into the act of prescribing.
John undertook medical school and PhD training in the UK. He completed psychiatry residency and clinical research fellowships at Yale. He is board certified in Psychiatry, Addiction Medicine and Clinical Informatics. He serves as Residency Program Director for the Yale Department of Psychiatry, Deputy Medical Director at Connecticut Mental Health Center and Chief of Behavioral Health at Continuum of Care Inc.
Appointments
Psychiatry
Associate Professor on TermPrimary
Other Departments & Organizations
- Division of Public Psychiatry Research
- Psychiatry
- Specialized Treatment for Early Psychosis (STEP) Program
Education & Training
- PhD
- University of Huddersfield, Translational neuroscience (2018)
- Fellow in Psychotic Disorders/ Community Psychiatry
- Yale University/ Connecticut Mental Health Center (2015)
- Fellow in Advanced Psychopharmacology
- Yale University/ West Haven VA (2014)
- Resident in Psychiatry
- Yale University (2012)
- BMBS
- University of Nottingham (2005)
Board Certifications
Clinical Informatics
- Certification Organization
- AB of Preventive Medicine
- Original Certification Date
- 2024
Addiction Medicine (Preventive Medicine)
- Certification Organization
- AB of Preventive Medicine
- Original Certification Date
- 2019
Psychiatry
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2012
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of John Cahill's published research.
Publications Timeline
A big-picture view of John Cahill's research output by year.
Vinod H. Srihari, MD
Deepak Cyril Dsouza, MBBS, MD
Albert Powers, MD, PhD
Clara Fonteneau, PhD
Fangyong Li, MS, MPH
Godfrey Pearlson, MA, MBBS
12Publications
222Citations
Publications
2024
The Academic Community Early Psychosis Intervention Network: Toward building a novel learning health system across six US states
Vohs J, Srihari V, Vinson A, Lapidos A, Cahill J, Taylor S, Heckers S, Weiss A, Chaudhry S, Silverstein S, Tso I, Breitborde N, Breier A. The Academic Community Early Psychosis Intervention Network: Toward building a novel learning health system across six US states. Learning Health Systems 2024 DOI: 10.1002/lrh2.10471.Peer-Reviewed Original ResearchConceptsEarly Psychosis Intervention NetworkIntervention NetworkFirst-episode psychosisRegional clinical networksLearning health systemQuality improvement projectQuality improvement effortsCulture of continuous learningData elementsPrimary diagnosis of schizophreniaConsecutive 6-month intervalsFirst-episode psychosis clinicUsual careSuperior patient outcomesSpecialty servicesHealth systemClinical teamImplementation meetingsQuality assurance effortsImprovement projectClinical networksHealthcare systemPractice-based researchImprovement effortsQuality improvementTimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis
Mathis W, Ferrara M, Cahill J, Karmani S, Tayfur S, Srihari V. TimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis. PLOS ONE 2024, 19: e0302116. PMID: 39028697, PMCID: PMC11259254, DOI: 10.1371/journal.pone.0302116.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsPathways to CareDuration of untreated psychosisManual transcription errorsDevelopment of targeted interventionsReduce duration of untreated psychosisHealthcare accessibility researchReal-time data entryImprove patient outcomesEpisode psychosisCare pathwaysPatient journeyHealthcare contextPatient outcomesPaper-basedConversion of collected dataFEP treatmentData collection processNew HavenData collection methodsData entryTranscription errorsUntreated psychosisOpen-source codebaseData collectionWeb-based toolAccelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker J, Bearden C, Billah T, Bouix S, Broome M, Buccilli K, Cadenhead K, Calkins M, Cannon T, Cecci G, Chen E, Cho K, Choi J, Clark S, Coleman M, Conus P, Corcoran C, Cornblatt B, Diaz-Caneja C, Dwyer D, Ebdrup B, Ellman L, Fusar-Poli P, Galindo L, Gaspar P, Gerber C, Glenthøj L, Glynn R, Harms M, Horton L, Kahn R, Kambeitz J, Kambeitz-Ilankovic L, Kane J, Kapur T, Keshavan M, Kim S, Koutsouleris N, Kubicki M, Kwon J, Langbein K, Lewandowski K, Light G, Mamah D, Marcy P, Mathalon D, McGorry P, Mittal V, Nordentoft M, Nunez A, Pasternak O, Pearlson G, Perez J, Perkins D, Powers A, Roalf D, Sabb F, Schiffman J, Shah J, Smesny S, Spark J, Stone W, Strauss G, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum I, Wolf D, Wolff P, Wood S, Yung A, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión R, Castro E, Cetin-Karayumak S, Chakravarty M, Cho Y, Cotter D, D’Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur R, Gur R, Hamilton H, Hoftman G, Jacobs G, Jarcho J, Ji J, Kohler C, Lalousis P, Lavoie S, Lepage M, Liebenthal E, Mervis J, Murty V, Nicholas S, Ning L, Penzel N, Poldrack R, Polosecki P, Pratt D, Rabin R, Eichi H, Rathi Y, Reichenberg A, Reinen J, Rogers J, Ruiz-Yu B, Scott I, Seitz-Holland J, Srihari V, Srivastava A, Thompson A, Turetsky B, Walsh B, Whitford T, Wigman J, Yao B, Yuen H, Ahmed U, Byun A, Chung Y, Do K, Hendricks L, Huynh K, Jeffries C, Lane E, Langholm C, Lin E, Mantua V, Santorelli G, Ruparel K, Zoupou E, Adasme T, Addamo L, Adery L, Ali M, Auther A, Aversa S, Baek S, Bates K, Bathery A, Bayer J, Beedham R, Bilgrami Z, Birch S, Bonoldi I, Borders O, Borgatti R, Brown L, Bruna A, Carrington H, Castillo-Passi R, Chen J, Cheng N, Ching A, Clifford C, Colton B, Contreras P, Corral S, Damiani S, Done M, Estradé A, Etuka B, Formica M, Furlan R, Geljic M, Germano C, Getachew R, Goncalves M, Haidar A, Hartmann J, Jo A, John O, Kerins S, Kerr M, Kesselring I, Kim H, Kim N, Kinney K, Krcmar M, Kotler E, Lafanechere M, Lee C, Llerena J, Markiewicz C, Matnejl P, Maturana A, Mavambu A, Mayol-Troncoso R, McDonnell A, McGowan A, McLaughlin D, McIlhenny R, McQueen B, Mebrahtu Y, Mensi M, Hui C, Suen Y, Wong S, Morrell N, Omar M, Partridge A, Phassouliotis C, Pichiecchio A, Politi P, Porter C, Provenzani U, Prunier N, Raj J, Ray S, Rayner V, Reyes M, Reynolds K, Rush S, Salinas C, Shetty J, Snowball C, Tod S, Turra-Fariña G, Valle D, Veale S, Whitson S, Wickham A, Youn S, Zamorano F, Zavaglia E, Zinberg J, Woods S, Shenton M. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin 2024, 50: 496-512. PMID: 38451304, PMCID: PMC11059785, DOI: 10.1093/schbul/sbae011.Peer-Reviewed Original ResearchCitationsAltmetricConceptsClinical high-risk individualsClinical high riskNational Institute of Mental HealthInstitute of Mental HealthAttenuated positive symptomsPersistent negative symptomsTransition to psychosisCHR statusHigh riskNegative symptomsPositive symptomsAnxiety symptomsPsychosocial functioningCognitive dataOutcomes of individualsDigital health technologiesDaily surveysPsychosisSCZPublic health needsMental healthNovel pharmacological interventionsSchizophreniaClinical outcomesHealth needsAdopting a Novel Approach to Prevent and Address Patient Mistreatment of Staff in a Community Mental Health Center
Steiner J, Belisle N, Cahill J, Garcia-Vassallo G, Johnson A, Lukens C, Oliva M, Pedersen K, Shetler D, Wassmer K, Wilkins K. Adopting a Novel Approach to Prevent and Address Patient Mistreatment of Staff in a Community Mental Health Center. Psychiatric Services 2024, 75: 492-495. PMID: 38291887, DOI: 10.1176/appi.ps.20230234.Peer-Reviewed Original ResearchAltmetricConceptsCommunity mental health centerMental health centerHealth centersVerbal mistreatmentCulture of safetyHealth care settingsPerformance improvement programCare settingsStaff membersPsychological impactStaffWell-beingClinical practiceImprovement programsAffective well-beingMistreatmentTrainingHealthCenterAddressConnecticutInitiationSupportProgramPractice
2022
Promoting the Success and Sustainability of Coordinated Specialty Care Teams in Ohio
Breitborde N, Parris C, Stearns W, Nawaz S, Seiber E, Hamilton S, Hefner J, Hogan T, Singh P, Knudsen K, Martt N, Srihari V, Cahill J, Jani A, Anagbonu F, Baughman C, Carpenter K, Dunivant C, Dunlap N, Guirgis H, Lazarus S, Moe A, Nguyen C, Wastler H, Montesano V. Promoting the Success and Sustainability of Coordinated Specialty Care Teams in Ohio. Psychiatric Services 2022, 74: 766-769. PMID: 36415991, DOI: 10.1176/appi.ps.20220126.Peer-Reviewed Original ResearchCitationsAltmetric
2017
Psychopharmacology Prescribing Workshops: A Novel Method for Teaching Psychiatry Residents How to Talk to Patients About Medications
Kavanagh EP, Cahill J, Arbuckle MR, Lenet AE, Subramanyam K, Winchel RM, Nossel I, DeSilva R, Caravella RA, Ackerman M, Park HC, Ross DA. Psychopharmacology Prescribing Workshops: A Novel Method for Teaching Psychiatry Residents How to Talk to Patients About Medications. Academic Psychiatry 2017, 41: 491-496. PMID: 28194682, DOI: 10.1007/s40596-017-0662-z.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsTwo-institutionClasses of medicationsSubset of residentsThird-year psychiatry residentsMedicationsClinical experiencePsychiatry residentsFacilitated group discussionPrescribing skillsInformed consentPatientsResultsThe courseSelf-assessment measuresResident comfortPost surveyCourseResidentsExperienced faculty membersPrescribingGroup discussions
2016
A Prescription for “Deprescribing” in Psychiatry
Gupta S, Cahill JD. A Prescription for “Deprescribing” in Psychiatry. Psychiatric Services 2016, 67: 904-907. PMID: 26975524, DOI: 10.1176/appi.ps.201500359.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLong-term adverse effectsRate of polypharmacyCessation of medicationIdentification of medicationsMeaning of medicationsStrong therapeutic allianceRegimen optimizationSpecific indicationsMedicationsGeriatric medicineAdverse effectsTherapeutic allianceAppropriate timingPatientsPsychiatryDeprescribingPolypharmacyRegimenReviewCaregiversCessation
2015
The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans
Cortes-Briones JA, Cahill JD, Skosnik PD, Mathalon DH, Williams A, Sewell RA, Roach BJ, Ford JM, Ranganathan M, D’Souza D. The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans. Biological Psychiatry 2015, 78: 805-813. PMID: 25913109, PMCID: PMC4627857, DOI: 10.1016/j.biopsych.2015.03.023.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPsychosis-like effectsPsychosis-like symptomsPsychotomimetic effectsNegative-like symptomsActive drug conditionsNeural noiseDose-related effectsDose-related mannerRandom neural activityDose-dependent mannerPrincipal active constituentHealthy humansPsychotic disordersCortical noiseDrug conditionsSymptomsΔ9-tetrahydrocannabinolBaseline periodDisorganization symptomsNeural activityCounterbalanced designTest dayActive constituentsOddball taskTHC
2014
Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study
Srihari VH, Tek C, Pollard J, Zimmet S, Keat J, Cahill JD, Kucukgoncu S, Walsh BC, Li F, Gueorguieva R, Levine N, Mesholam-Gately RI, Friedman-Yakoobian M, Seidman LJ, Keshavan MS, McGlashan TH, Woods SW. Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study. BMC Psychiatry 2014, 14: 335. PMID: 25471062, PMCID: PMC4262386, DOI: 10.1186/s12888-014-0335-3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsEarly detectionEarly outcomesGeographic catchmentTIPS studyYounger patientsAppropriate patientsUntreated psychosisPsychosis onsetEffective treatmentCare providersPsychotic symptomsPublic education campaignsPsychotic disordersHelp-seeking behaviorSecondary aimComprehensive interventionPatientsIntervention servicesDUPEducation campaignsOutcomesSocial marketing approachPrimary aimTreatmentFESTesting differences in the activity of event-related potential sources: Important implications for clinical researchers
Cortes-Briones JA, Cahill JD, Ranganathan M, Sewell RA, D’Souza D, Skosnik PD. Testing differences in the activity of event-related potential sources: Important implications for clinical researchers. Clinical Neurophysiology 2014, 126: 215-218. PMID: 24840905, DOI: 10.1016/j.clinph.2014.04.008.Peer-Reviewed Original ResearchCitations
Clinical Trials
Current Trials
Sleep Dependent Learning in Schizophrenia and Psychosis Risk Syndrome
HIC ID1201009524RoleSub InvestigatorPrimary Completion Date01/31/2022Recruiting ParticipantsGenderBothAge18 years - 55 years
News
News
- August 13, 2024
Cahill Selected to be Director of Yale Psychiatry Residency Program
- February 01, 2024Source: Psychiatric Services
Adopting a Novel Approach to Prevent and Address Patient Mistreatment of Staff in a Community Mental Health Center
- February 01, 2022
Mindmap Reduced Duration of Untreated Psychosis in the New Haven Area
- June 15, 2021
Connecticut Mental Health Center Announces Faculty Appointments
Get In Touch
Contacts
Email
Academic Office Number
Clinical Inquiry Number
Clinic Fax Number